Sera Prognostics, Inc. (SERA)
2.16
-0.14
(-6.09%)
USD |
NASDAQ |
Apr 07, 16:00
2.195
+0.04
(+1.62%)
After-Hours: 20:00
Sera Prognostics Total Liabilities (Quarterly) : 27.14M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Co-Diagnostics, Inc. | 6.488M |
| Celldex Therapeutics, Inc. | 55.82M |
| Plus Therapeutics, Inc. | 12.33M |
| Atossa Therapeutics, Inc. | 8.255M |
| Abeona Therapeutics, Inc. | 61.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 102.55M |
| Shareholders Equity (Quarterly) | 75.41M |
| Debt to Equity Ratio | 0.031 |
| Current Ratio | 1.686 |
| Net Debt Paydown Yield | -0.22% |